North America Liver Disease Diagnostics Market

North America Liver Disease Diagnostics Market By End User (Hospitals, Laboratories and Other End Users), By Diagnosis Technique (Imaging, Biopsy, Endoscopy, Laboratory tests and Other Diagnosis Techniques), By Country, Industry Analysis and Forecast, 2020 - 2026

Report Id: KBV-4394 Publication Date: July-2020 Number of Pages: 75
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Liver Disease Diagnostics Market, by End User
1.4.2 North America Liver Disease Diagnostics Market, by Diagnosis Technique
1.4.3 North America Liver Disease Diagnostics Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. North America Liver Disease Diagnostics Market by End User
3.1 North America Hospitals Market by Country
3.2 North America Laboratories Market by Country
3.3 North America Other End Users Market by Country

Chapter 4. North America Liver Disease Diagnostics Market by Diagnosis Technique
4.1 North America Imaging Market by Country
4.2 North America Biopsy Market by Country
4.3 North America Endoscopy Market by Country
4.4 North America Laboratory tests Market by Country
4.5 North America Other Diagnosis Techniques Market by Country

Chapter 5. North America Liver Disease Diagnostics Market by Country
5.1 US Liver Disease Diagnostics Market
5.1.1 US Liver Disease Diagnostics Market by End User
5.1.2 US Liver Disease Diagnostics Market by Diagnosis Technique
5.2 Canada Liver Disease Diagnostics Market
5.2.1 Canada Liver Disease Diagnostics Market by End User
5.2.2 Canada Liver Disease Diagnostics Market by Diagnosis Technique
5.3 Mexico Liver Disease Diagnostics Market
5.3.1 Mexico Liver Disease Diagnostics Market by End User
5.3.2 Mexico Liver Disease Diagnostics Market by Diagnosis Technique
5.4 Rest of North America Liver Disease Diagnostics Market
5.4.1 Rest of North America Liver Disease Diagnostics Market by End User
5.4.2 Rest of North America Liver Disease Diagnostics Market by Diagnosis Technique

Chapter 6. Company Profiles
6.1 Abbott Laboratories
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Partnerships, Collaborations, and Agreements:
6.1.5.2 Acquisition and Mergers:
6.1.5.3 Approvals:
6.2 F. Hoffmann-La Roche Ltd.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent strategies and developments:
6.2.5.1 Approvals:
6.3 Boston Scientific Corporation
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Acquisition and Mergers:
6.4 Siemens AG (Siemens Healthineers)
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.4.5 Recent strategies and developments:
6.4.5.1 Partnerships, Collaborations, and Agreements:
6.4.5.2 Acquisition and Mergers:
6.4.5.3 Product Launches and Product Expansions:
6.5 Bayer AG
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.6 Merck & Co., Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expenses
6.7 Sanofi S.A.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expense
6.8 Novartis AG
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.9 Pfizer, Inc.
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental and Regional Analysis
6.9.4 Research & Development Expense
6.1 Randox Laboratories Limited
6.10.1 Company Overview
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo